By Iker Seisdedos (El País)
Marjorie Smith was not well.
The combination of a leukemia diagnosis and a divorce had plunged her into a deep depression.
She had discovered during her readings that psilocybin, the active ingredient in hallucinogenic mushrooms, could help combat the anxiety that patients in her situation suffer from.
So she told her oncologist:
“If one day there are
clinical trials
, count on me.
»
And this day has arrived.
She put on a mask, plugged in headphones playing instrumental music, ingested a large dose of the powerful psychedelic substance, and lay down on the couch.
Half an hour later, she had an anxiety attack.
She had the impression of being in a “
slush fund”
from which she wanted to get out at all costs.
The psychologist who accompanied him and who had participated in the preparatory sessions managed to calm him down with breathing exercises.
The patient…
This article is reserved for subscribers.
You have 97% left to discover.
Flash sale
-70% on digital subscription
I ENJOY IT
Already subscribed?
Log in